Frontiers in Cardiovascular Medicine (Jun 2023)
Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials
Abstract
No abstracts available.Keywords
Frontiers in Cardiovascular Medicine (Jun 2023)